Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA and LAC in Takotsubo Cardiomyopathy
NCT01524861Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Dec 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Takotsubo cardiomyopathy (TCM) comparing Placebo, alpha-lipoic acid and L-acetyl carnitine (3 arms). Primary endpoint: Change from Baseline in Adrenergic cardiac innervation at 12 months. Started Dec 2011; status: completed.
02
Drugs
alpha-lipoic acidacetyl-l-carnitine
03
Conditions
Takotsubo cardiomyopathy (TCM)
Beyond the preview
Go deeper on NCT01524861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524861.